SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-23-046466
Filing Date
2023-04-18
Accepted
2023-04-18 09:19:46
Documents
3
Period of Report
2023-04-18

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2313068d1_6k.htm 6-K 16044
2 EXHIBIT 99.1 tm2313068d1_ex99-1.htm EX-99.1 14370
3 GRAPHIC tm2313068d1_ex99-1img01.jpg GRAPHIC 5400
  Complete submission text file 0001104659-23-046466.txt   38993
Mailing Address BREDGADE 34E COPENHAGEN K G7 1260
Business Address BREDGADE 34E COPENHAGEN K G7 1260 4531262615
Evaxion Biotech A/S (Filer) CIK: 0001828253 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39950 | Film No.: 23825664
SIC: 2836 Biological Products, (No Diagnostic Substances)